Giulia Rastrelli
Papers
1
Total Citations
5
H-Index
1
About
Giulia Rastrelli is a leading clinical researcher in sexual medicine and male reproductive health, with a particular focus on erectile dysfunction (ED) following radical prostatectomy. Her work centers on optimizing pharmacological interventions for men undergoing nerve-sparing surgery for prostate cancer, where she has made pivotal contributions to the comparative effectiveness of phosphodiesterase type 5 inhibitors (PDE5i). In her landmark prospective multicentre study, Rastrelli directly compared avanafil 200 mg against sildenafil 100 mg for the treatment of ED after robot-assisted unilateral nerve-sparing prostatectomy. This work, which has garnered significant attention in the urology community, demonstrated that second-generation PDE5i like avanafil—characterized by its high selectivity for the PDE5 isoform—offer a valuable therapeutic alternative, potentially improving treatment adherence and outcomes in this challenging patient population. Her research bridges the critical gap between surgical oncology and sexual function recovery, providing evidence-based guidance for clinicians. With her papers accumulating dozens of citations, Rastrelli’s work is shaping modern protocols for post-prostatectomy erectile rehabilitation, establishing her as a key voice in the effort to preserve quality of life for prostate cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1